Investing.com -- Medifast (NYSE:MED), a health and wellness company, has seen an increase in its shares by up to 4.9% following the launch of a new product line.
The new products are high-protein, fiber-rich mini meals and a daily nutrient pack. These are specifically designed for individuals who are on GLP-1 medications and for those seeking assistance in maintaining their weight.
The GLP-1 medications are typically prescribed to individuals with certain health conditions, and the new product line by Medifast aims to cater to their dietary needs.
“Obesity is a chronic health condition, and findings from a recent clinical trial suggest that ongoing support is essential for sustaining progress in weight and overall health,” Satya Jonnalagadda, Vice President of Scientific and Clinical Affairs at Medifast said in a press release.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.